Skip to main content
Top
Published in: Clinical Research in Cardiology 4/2018

01-04-2018 | Original Paper

Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Authors: Stephane Fournier, Olivier Muller, Umberto Benedetto, Marco Roffi, Thomas Pilgrim, Franz R. Eberli, Hans Rickli, Dragana Radovanovic, Paul Erne, Stéphane Cook, Stéphane Noble, Rachel Fesselet, Andrea Zuffi, Sophie Degrauwe, PierGiorgio Masci, Stephan Windecker, Eric Eeckhout, Juan F. Iglesias, on behalf on the AMIS Plus Investigators

Published in: Clinical Research in Cardiology | Issue 4/2018

Login to get access

Abstract

Background

The clinical benefit of manual thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) in patients with ST-segment elevation myocardial infarction (STEMI) remains uncertain. This study assessed the impact of circadian rhythms on the effectiveness of manual TA.

Methods and results

We conducted an observational study of patients enrolled in the Acute Myocardial Infarction in Switzerland Plus registry. STEMI patients undergoing PPCI with (TA group) or without (PCI-alone group) manual TA were divided based on time-of-day symptom onset: group 1 (00:00–05:59), group 2 (06:00–11:59), group 3 (12:00–17:59) and group 4 (18:00–23:59). The primary endpoint was circadian variation of myocardial infarction (MI) size. The secondary endpoint was in-hospital all-cause mortality. Between 2009 and 2014, 3648 patients underwent PPCI (TA, 49%). After propensity-score matching, 2860 patients were included. Minimal myocardial Injury was observed in groups 2 and 3 (peak creatine kinase level group 1, 2723 ± 148 U/l; group 2, 2493 ± 105 U/l; group 3, 2550 ± 106 U/l; group 4, 2952 ± 144 U/l; p = 0.044) in the TA group, whereas no time-of-day dependence was found in PCI-alone group. After periodic sinusoidal regression analysis, a circadian relationship between time-of-day symptom onset and MI size was demonstrated in the TA group (p < 0.001). In-hospital all-cause mortality was 3.4% in the TA group and 4.3% in the PCI-alone group (p = 0.20).

Conclusions

In this large registry of STEMI patients, manual TA did not reduce in-hospital all-cause mortality. Nonetheless, there was a circadian dependence of TA effectiveness with greatest myocardial salvage for patients with symptom onset between 06:00 and 17:59.
Literature
1.
go back to reference Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20CrossRefPubMed Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20CrossRefPubMed
2.
go back to reference Noman A, Egred M, Bagnall A, Spyridopoulos I, Jamieson S, Ahmed J (2012) Impact of thrombus aspiration during primary percutaneous coronary intervention on mortality in ST-segment elevation myocardial infarction. Eur Heart J 33:3054–3061CrossRefPubMed Noman A, Egred M, Bagnall A, Spyridopoulos I, Jamieson S, Ahmed J (2012) Impact of thrombus aspiration during primary percutaneous coronary intervention on mortality in ST-segment elevation myocardial infarction. Eur Heart J 33:3054–3061CrossRefPubMed
3.
go back to reference de Waha S, Desch S, Eitel I et al (2012) Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. Clin Res Cardiol 101:487–495CrossRefPubMed de Waha S, Desch S, Eitel I et al (2012) Relationship and prognostic value of microvascular obstruction and infarct size in ST-elevation myocardial infarction as visualized by magnetic resonance imaging. Clin Res Cardiol 101:487–495CrossRefPubMed
4.
go back to reference Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2009) Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction. Clin Res Cardiol 98:773–779CrossRefPubMed Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2009) Predictors and short-term prognosis of angiographically detected distal embolization after emergency percutaneous coronary intervention for ST-elevation acute myocardial infarction. Clin Res Cardiol 98:773–779CrossRefPubMed
5.
go back to reference Svilaas T, Vlaar PJ, van der Horst IC et al (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358:557–567CrossRefPubMed Svilaas T, Vlaar PJ, van der Horst IC et al (2008) Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358:557–567CrossRefPubMed
6.
go back to reference Vlaar PJ, Svilaas T, van der Horst IC et al (2008) Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371:1915–1920CrossRefPubMed Vlaar PJ, Svilaas T, van der Horst IC et al (2008) Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371:1915–1920CrossRefPubMed
7.
go back to reference Frobert O, Lagerqvist B, Olivecrona GK et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369:1587–1597CrossRefPubMed Frobert O, Lagerqvist B, Olivecrona GK et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369:1587–1597CrossRefPubMed
8.
go back to reference Lagerqvist B, Frobert O, Olivecrona GK et al (2014) Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 371:1111–1120CrossRefPubMed Lagerqvist B, Frobert O, Olivecrona GK et al (2014) Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 371:1111–1120CrossRefPubMed
9.
10.
go back to reference Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL (2013) Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol 62:1409–1418CrossRefPubMed Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL (2013) Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol 62:1409–1418CrossRefPubMed
11.
go back to reference Elgendy IY, Huo T, Bhatt DL, Bavry AA (2015) Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ Cardiovasc Interv 8:e002258CrossRefPubMed Elgendy IY, Huo T, Bhatt DL, Bavry AA (2015) Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ Cardiovasc Interv 8:e002258CrossRefPubMed
12.
go back to reference Harle T, Zeymer U, Hochadel M et al (2015) Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry. Clin Res Cardiol 104:803–811CrossRefPubMed Harle T, Zeymer U, Hochadel M et al (2015) Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry. Clin Res Cardiol 104:803–811CrossRefPubMed
14.
go back to reference Fournier S, Taffe P, Radovanovic D et al (2015) Myocardial infarct size and mortality depend on the time of day-a large multicenter study. PLoS One 10:e0119157CrossRefPubMedPubMedCentral Fournier S, Taffe P, Radovanovic D et al (2015) Myocardial infarct size and mortality depend on the time of day-a large multicenter study. PLoS One 10:e0119157CrossRefPubMedPubMedCentral
15.
go back to reference Reiter R, Swingen C, Moore L, Henry TD, Traverse JH (2012) Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res 110:105–110CrossRefPubMed Reiter R, Swingen C, Moore L, Henry TD, Traverse JH (2012) Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res 110:105–110CrossRefPubMed
16.
go back to reference Suarez-Barrientos A, Lopez-Romero P, Vivas D et al (2011) Circadian variations of infarct size in acute myocardial infarction. Heart 97:970–976CrossRefPubMed Suarez-Barrientos A, Lopez-Romero P, Vivas D et al (2011) Circadian variations of infarct size in acute myocardial infarction. Heart 97:970–976CrossRefPubMed
17.
go back to reference Fournier S, Eeckhout E, Mangiacapra F et al (2012) Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 163:208–213CrossRefPubMed Fournier S, Eeckhout E, Mangiacapra F et al (2012) Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 163:208–213CrossRefPubMed
18.
go back to reference Kurnik PB (1995) Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 91:1341–1346CrossRefPubMed Kurnik PB (1995) Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 91:1341–1346CrossRefPubMed
19.
go back to reference Kono T, Morita H, Nishina T et al (1996) Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 27:774–778CrossRefPubMed Kono T, Morita H, Nishina T et al (1996) Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 27:774–778CrossRefPubMed
20.
go back to reference Radovanovic D, Erne P (2010) AMIS plus: swiss registry of acute coronary syndrome. Heart 96:917–921CrossRefPubMed Radovanovic D, Erne P (2010) AMIS plus: swiss registry of acute coronary syndrome. Heart 96:917–921CrossRefPubMed
21.
go back to reference Muller JE, Stone PH, Turi ZG et al (1985) Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313:1315–1322CrossRefPubMed Muller JE, Stone PH, Turi ZG et al (1985) Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313:1315–1322CrossRefPubMed
22.
go back to reference Panza JA, Epstein SE, Quyyumi AA (1991) Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 325:986–990CrossRefPubMed Panza JA, Epstein SE, Quyyumi AA (1991) Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 325:986–990CrossRefPubMed
23.
go back to reference Petralito A, Mangiafico RA, Gibiino S, Cuffari MA, Miano MF, Fiore CE (1982) Daily modifications of plasma fibrinogen platelets aggregation, Howell’s time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease. Chronobiologia 9:195–201PubMed Petralito A, Mangiafico RA, Gibiino S, Cuffari MA, Miano MF, Fiore CE (1982) Daily modifications of plasma fibrinogen platelets aggregation, Howell’s time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease. Chronobiologia 9:195–201PubMed
24.
go back to reference Rea MS, Figueiro MG, Sharkey KM, Carskadon MA (2012) Relationship of morning cortisol to circadian phase and rising time in young adults with delayed sleep times. Int J Endocrinol 2012:749460CrossRefPubMedPubMedCentral Rea MS, Figueiro MG, Sharkey KM, Carskadon MA (2012) Relationship of morning cortisol to circadian phase and rising time in young adults with delayed sleep times. Int J Endocrinol 2012:749460CrossRefPubMedPubMedCentral
25.
go back to reference Tofler GH, Brezinski D, Schafer AI et al (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316:1514–1518CrossRefPubMed Tofler GH, Brezinski D, Schafer AI et al (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316:1514–1518CrossRefPubMed
26.
go back to reference Scheer FA, Michelson AD, Frelinger AL 3rd et al (2011) The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One 6:e24549CrossRefPubMedPubMedCentral Scheer FA, Michelson AD, Frelinger AL 3rd et al (2011) The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One 6:e24549CrossRefPubMedPubMedCentral
27.
go back to reference Grimaudo V, Hauert J, Bachmann F, Kruithof EK (1988) Diurnal variation of the fibrinolytic system. Thromb Haemost 59:495–499PubMed Grimaudo V, Hauert J, Bachmann F, Kruithof EK (1988) Diurnal variation of the fibrinolytic system. Thromb Haemost 59:495–499PubMed
28.
29.
go back to reference De Luca G, Suryapranata H, Ottervanger JP et al (2005) Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 150:1185–1189CrossRefPubMed De Luca G, Suryapranata H, Ottervanger JP et al (2005) Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 150:1185–1189CrossRefPubMed
30.
go back to reference Durgan DJ, Pulinilkunnil T, Villegas-Montoya C et al (2010) Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res 106:546–550CrossRefPubMed Durgan DJ, Pulinilkunnil T, Villegas-Montoya C et al (2010) Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res 106:546–550CrossRefPubMed
31.
go back to reference Wieringa WG, Lexis CP, Mahmoud KD et al (2014) Time of symptom onset and value of myocardial blush and infarct size on prognosis in patients with ST-elevation myocardial infarction. Chronobiol Int 31:797–806CrossRefPubMed Wieringa WG, Lexis CP, Mahmoud KD et al (2014) Time of symptom onset and value of myocardial blush and infarct size on prognosis in patients with ST-elevation myocardial infarction. Chronobiol Int 31:797–806CrossRefPubMed
32.
go back to reference Leibundgut G, Gick M, Morel O et al (2016) Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction. Clin Res Cardiol 105:432–440CrossRefPubMed Leibundgut G, Gick M, Morel O et al (2016) Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction. Clin Res Cardiol 105:432–440CrossRefPubMed
33.
go back to reference Fournier S, Iten L, Marques-Vidal P et al (2017) Circadian rhythm of blood cardiac troponin T concentration. Clin Res Cardiol 106(12):1026–1032CrossRefPubMed Fournier S, Iten L, Marques-Vidal P et al (2017) Circadian rhythm of blood cardiac troponin T concentration. Clin Res Cardiol 106(12):1026–1032CrossRefPubMed
34.
go back to reference Bouma W, Willemsen HM, Lexis CP et al (2016) Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Clin Res Cardiol 105:981–991CrossRefPubMedPubMedCentral Bouma W, Willemsen HM, Lexis CP et al (2016) Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction. Clin Res Cardiol 105:981–991CrossRefPubMedPubMedCentral
35.
go back to reference Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415–423CrossRefPubMed Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415–423CrossRefPubMed
36.
go back to reference Kleber FX, Rittger H, Ludwig J et al (2016) Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 105:613–621CrossRefPubMed Kleber FX, Rittger H, Ludwig J et al (2016) Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial. Clin Res Cardiol 105:613–621CrossRefPubMed
37.
go back to reference Ferenc M, Buettner HJ, Gick M et al (2016) Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents. Clin Res Cardiol 105:230–238CrossRefPubMed Ferenc M, Buettner HJ, Gick M et al (2016) Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents. Clin Res Cardiol 105:230–238CrossRefPubMed
38.
go back to reference van der Heijden LC, Kok MM, Lam MK et al (2016) Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clin Res Cardiol 105:206–215CrossRefPubMed van der Heijden LC, Kok MM, Lam MK et al (2016) Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clin Res Cardiol 105:206–215CrossRefPubMed
39.
go back to reference Ong P, Sechtem U (2016) Controversies in the treatment of patients with STEMI and multivessel disease: is it time for PCI of all lesions? Clin Res Cardiol 105:467–470CrossRefPubMed Ong P, Sechtem U (2016) Controversies in the treatment of patients with STEMI and multivessel disease: is it time for PCI of all lesions? Clin Res Cardiol 105:467–470CrossRefPubMed
40.
go back to reference de Waha S, Eitel I, Desch S et al (2015) Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol 104:727–734CrossRefPubMed de Waha S, Eitel I, Desch S et al (2015) Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol 104:727–734CrossRefPubMed
Metadata
Title
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Authors
Stephane Fournier
Olivier Muller
Umberto Benedetto
Marco Roffi
Thomas Pilgrim
Franz R. Eberli
Hans Rickli
Dragana Radovanovic
Paul Erne
Stéphane Cook
Stéphane Noble
Rachel Fesselet
Andrea Zuffi
Sophie Degrauwe
PierGiorgio Masci
Stephan Windecker
Eric Eeckhout
Juan F. Iglesias
on behalf on the AMIS Plus Investigators
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 4/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1189-8

Other articles of this Issue 4/2018

Clinical Research in Cardiology 4/2018 Go to the issue